• English
  • Deutsch
  • Log In
    Password Login
    or
  • Research Outputs
  • Projects
  • Researchers
  • Institutes
  • Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Patente
  4. Humanes Clarazell-spezifisches Antigen und dessen Antikoerper SEC-41 sowie Hybridoma Han-41
 
  • Details
Options
Title

Humanes Clarazell-spezifisches Antigen und dessen Antikoerper SEC-41 sowie Hybridoma Han-41

Date Issued
1992
Author(s)
Ochiai, A.
Emura, M.
Mohr, U.
Patent No
1991-4105374
Abstract
The invention refers to the new monoclonal antibody SEC-41 and the hybridoma cell line Han-41, which produces this antibody and to the use of the antibody. The hybridoma cell line (DSM ACC2002) produces a monoclonal antibody which detects the glycoprotein, having a molecular weight of about 52,000 Daltons, in human broncho-alveolar lavage samples. Moreover, the monoclonal antibody according to the invention has an immunhistochemical reaction with type II pneumocytes and Clara cells of the adult human lung tissue. In addition, the monoclonal antibody (SEC-41) detects human lung epithelial cells in the female foetus of the 18th week of pregnancy.
Language
de
Institute
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM
Link
http://worldwide.espacenet.com/publicationDetails/biblio?DB=worldwide.espacenet.com&locale=en_EP&FT=D&CC=DE&NR=4105374A
Patenprio
DE 1991-4105374 A: 19910221
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Send Feedback
© 2022